Two Sigma Advisers’s BioAtla BCAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.58K | Sell |
14,100
-174,800
| -93% | -$69.2K | ﹤0.01% | 2299 |
|
|
2025
Q1 | $65.5K | Buy |
188,900
+127,400
| +207% | +$44.2K | ﹤0.01% | 2294 |
|
|
2024
Q4 | $36.4K | Sell |
61,500
-30,546
| -33% | -$18.1K | ﹤0.01% | 2304 |
|
|
2024
Q3 | $162K | Sell |
92,046
-61,254
| -40% | -$108K | ﹤0.01% | 2109 |
|
|
2024
Q2 | $210K | Sell |
153,300
-146,400
| -49% | -$201K | ﹤0.01% | 2196 |
|
|
2024
Q1 | $1.03M | Buy |
299,700
+38,800
| +15% | +$133K | ﹤0.01% | 1569 |
|
|
2023
Q4 | $642K | Buy |
260,900
+4,200
| +2% | +$10.3K | ﹤0.01% | 1822 |
|
|
2023
Q3 | $436K | Sell |
256,700
-45,700
| -15% | -$77.7K | ﹤0.01% | 1838 |
|
|
2023
Q2 | $907K | Sell |
302,400
-49,800
| -14% | -$149K | ﹤0.01% | 1575 |
|
|
2023
Q1 | $944K | Buy |
352,200
+3,000
| +0.9% | +$8.04K | ﹤0.01% | 1662 |
|
|
2022
Q4 | $2.88M | Sell |
349,200
-8,800
| -2% | -$72.6K | 0.01% | 1039 |
|
|
2022
Q3 | $2.76M | Sell |
358,000
-60,800
| -15% | -$468K | 0.01% | 1012 |
|
|
2022
Q2 | $1.19M | Buy |
418,800
+118,000
| +39% | +$336K | ﹤0.01% | 1496 |
|
|
2022
Q1 | $1.5M | Buy |
300,800
+149,700
| +99% | +$749K | ﹤0.01% | 1414 |
|
|
2021
Q4 | $2.97M | Buy |
+151,100
| New | +$2.97M | 0.01% | 1003 |
|